The primary action of GLP-1 and GIP is to potentiate insulin secretion in a glucose-dependent manner, a phenomenon referred to as the incretin effect (Mcintyre et al., 1964
We dont currently have a good handle on whats causing that variation so the best advice for now would be to check your own levels, and then make a decision based on those in conjunction with your healthcare provider
This debate is especially relevant for India as reports suggest large sales and adoption of GLP-1 among affluent urban consumers across Mumbai, Delhi, and Bengaluru
This is crucial as NF-B plays a pivotal role in regulating pro-inflammatory gene expression
To ensure transparency and address the completeness of the data presentation, representative full-membrane images have been included in the Supplementary File accompanying this paper
If you're also taking insulin or sulfonylureas, your risk of hypoglycaemia may increase, requiring a personalised monitoring plan